Medlemstidning för Svensk Förening för Diabetologi Aktuell Info för medlemmar

Åke Sjöholm Lipotoxicitet vid diabetes - fullständig referenslista

1. Efendic´ S, Luft R, Wajngot A. Aspects of the pathogenesis of type 2 diabetes. Endocrine Rev 1984; 5:395-410.

2. Malaisse WJ. The beta cell in non-insulin dependent diabetes: giving light to the blind. Diabetologia 1994; 37:S36-S42.

3. DeFronzo RA. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992; 15: 318-68.

4. Polonsky KS. The ß-cell in diabetes: from molecular genetics to clinical research. Diabetes 1995; 44: 705-17.

5. Porte D. Beta-cells in type II diabetes mellitus. Diabetes 1991; 40: 166-80.

6. Sjöholm Å. Diabetes mellitus and impaired pancreatic ß-cell proliferation. J Internal Med 1996; 239: 211-20.

7. Sjöholm Å. Invited review. Role of polyamines in the regulation of proliferation and hormone production by insulin-secreting cells. Am J Physiol 1993; 264: C501-18.

8. Larsson O, Barker CJ, Sjöholm Å, Carlqvist H, Michell RH, Bertorello A, Nilsson T, Honkanen R, Mayr GW,Zwiller J, Berggren P-O. Inhibition of phosphatases and increased Ca2+ channel activity by inositol hexakisphosphate. Science 1997; 278: 471-474.

9. MacDonald MJ. Elusive proximal signals of ß-cells for insulin secretion. Diabetes 1990; 39: 1461-66.

10. Newgard CB, McGarry JD. Metabolic coupling factors in pancreatic ß-cell signal transduction. Ann Rev Biochem 1995; 64: 689-719.

11. Taskinen MR, Lahdenperä S, Syvänne M. New insights into lipid metabolism in non-insulin-dependent diabetes mellitus. Ann. Med. 1996; 28: 335-40.

12. Leahy JL, Bonner-Weir S, Weir GC. ß-cell dysfunction induced by chronic hyperglycemia. Diabetes Care 1992; 15: 442-55.

13. Yki-Järvinen H. Glucose toxicity. Endocrine Rev 1992; 13: 415-31.

14. Unger RH. Diabetic hyperglycemia: link to impaired glucose transport in pancreatic ß-cells. Science 1991; 251:1200-5.

15. Kahn CR. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994; 43: 1066-84.

16. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997; 20: 614-620.

17. Sacks FM, Pfeffer MA, Moye LA. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-9.

18. Giroix M-H, Vesco L, Portha B. Functional and metabolic perturbations in isolated pancreatic islets from the GK rat, a genetic model of noninsulin-dependent diabetes. Endocrinology 1993; 132: 815-22.

19. Prentki M. New insights into pancreatic ß-cell metabolic signaling in insulin secretion. Eur J Endocrinol 1996; 134: 272-286.

20. Thorens B, Wu YJ, Leahy JL, Weir GC. The loss of GLUT-2 expression by glucose-unresponsive ß-cells of db/db mice is reversible and induced by the diabetic environment. J Clin Invest 1992; 90: 77-85.

21. Zhou Y-P, Östenson C-G, Ling Z-C, Grill V. Deficiency of pyruvate dehydrogenase activity in pancreatic islets of diabetic GK rats. Endocrinology 1995; 136: 3546-51.

22. Zhou Y-P, Grill VE. Palmitate-induced ß-cell insensitivity to glucose is coupled to decreased pyruvate dehydrogenase activity and enhanced kinase activity in rat pancreatic islets. Diabetes 1995; 44: 394-9.

23. Östenson C-G, Abdul-Halim S, Rasschaert J. et al. Deficient activity of FAD-linked glycerophosphate dehydrogenase in islets of GK rats. Diabetologia 1993; 36: 722-6.

24. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH. ß-cell lipotoxicity in the pathogenesis of non-insulin dependent diabetes mellitus of obese rats: impairment in adipocyte-ß-cell relationships. Proc Natl Acad Sci USA 1994; 91:10878-82.

25. McGarry JD. What if Minkowski had been ageusic? an alternative angle on diabetes. Science 1992; 258:766-70.

26. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications.Diabetes 1995; 44: 863-70.

27. Prentki M, Corkey BE. Are the ß-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 1996; 45: 273-83.

28. Assimacopoulos-Jeannet F, Thumelin S, Roche E, Esser V, McGarry JD, Prentki M. Fatty acids rapidly induce the carnitine palmitoyltransferase I gene in the pancreatic ß-cell line INS-1. J Biol Chem 1997; 272:1659-64.

29. Brun T, Assimacopoulos-Jeannet F, Corkey BE, Prentki M. Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic ß-cell line INS-1. Diabetes 1997; 46: 393-400.

30. Sako Y, Grill VE. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 1990; 127: 1580-9.

31. Zhou Y-P, Grill V. Long term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 1994; 93: 870-6.

32. Zhou Y-P, Grill V. Long-term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. J Clin Endocrinol Metab 1995; 80: 1584-90.

33. Björklund A, Yaney G, McGarry JD, Weir G. Fatty acids and beta-cell function. Diabetologia 1997; 40:B21-B26.

34. Zhou Y-P, Priestman DA, Randle PJ, Grill VE. Fasting and decreased B cell sensitivity: important role of fatty acid-induced inhibition of PDH activity. Am J Physiol 1996; 270: E988-E994.

35. Larsson O, Deeney JT, Bränström R, Berggren P-O, Corkey BE. Activation of the ATP-sensitive K+ channel by long chain acyl-CoA. A role in modulation of pancreatic ß-cell glucose sensitivity. J Biol Chem 1996; 271:10623-6.

36. Bränström R, Corkey BE, Berggren P-O, Larsson O. Evidence for a unique long chain acyl-CoA ester binding site on the ATP-sensitive K+ channel in mouse pancreatic beta cells. J Biol Chem 1997; 272: 17390-4.

37. Campfield LA, Smith FJ, Burn P. The OB protein (leptin) pathway - a link between adipose tissue mass and central neural networks. Horm Met Res 1996; 28: 619-32.

38. Koyama K, Chen G, Wang MY, Lee Y, Shimabukuro M, Newgard CB, Unger RH. Beta-cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy. Diabetes 1997; 48: 1276-1280.

39. Chen NG, Swick AG, Romsos DR. Leptin constrains acetylcholine-induced insulin secretion from pancreatic islets of ob/ob mice. J Clin Invest 1997; 100: 1174-1179.

40. Zhou YT, Shimabukuro M, Koyama K, Lee Y, Wang MY, Trieu F, Newgard CB, Unger RH. Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc Natl Acad Sci USA 1997; 94: 6386-6390.

41. Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB, Unger RH. Direct antidiabetogenic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 1997; 94:4242-4245.

[Innehåll] [Redaktören] [Ordföran den] [Sett & Hört] [Aktuell Info] [Redaktionen] [Arkivet] [Länkar] [Diskussionsforum] [Diabetes Update]
Till Förstasidan